
Sino Biopharm (1177.HK) Announces 2022 Annual Results
HONG KONG, Mar 31, 2023 – (ACN Newswire via SEAPRWire.com) – Sino Biopharmaceutical Limited (“Sino Biopharm” or the “Company”, together with its subsidiaries, the “Group”) (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in […]